Lumexa Imaging
LMRI
10.24
-0.35
-3.31%
Lumexa Imaging
US · LMRI
#3235 by market cap
Listed 2025
10.24
-0.35
-3.31%
Live - 5344 symbols - heartbeat 269s ago
· 2026-10-08 09:55
Pre-market
10.56
-0.28%
After-hours
10.59
0.00%
- Market cap
- 983.81M
- P/E (TTM)i
- -35.43
- P/Bi
- 1.60
- EPSi
- -0.49
- Div yieldi
- 0.00%
- 52W posi
- 29%
Reader sentiment
Are you bullish or bearish on LMRI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 112.84% 0.00pp
- Institutions
- 129
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
VC/PE Fund73.09%
Mutual Fund24.76%
Hedge Fund7.35%
Private Company6.52%
Individual/Insider1.33%
Government Pension Fund0.80%
Public Company0.29%
Top holders as of 2025-12-31
Welsh, Carson, Anderson & Stowe, L.P.
69.57% · 66.84M sh
Charlotte Radiology Investors, LLC
6.09% · 5.85M sh
Brown Advisory Incorporated
6.01% · 5.78M sh
MFS Investment Management
3.59% · 3.45M sh
WCAS Management Corporation
3.52% · 3.38M sh
Think Investments LP
2.66% · 2.56M sh
Janus Henderson Group plc
2.24% · 2.15M sh
BlackRock
1.46% · 1.40M sh
Vanguard Capital Management, LLC
1.28% · 1.23M sh
John Perkins
1.20% · 1.15M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
36 filings tracked · 19 buys · 0 sells
| Name | Role | Stake |
|---|---|---|
| Welsh, Carson, Anderson & Stowe, L.P. | -- | 69.57% |
| Julie Szeker | Chief Legal Officer | 0.06% |
| Brett Brodnax | Independent Director | 0.04% |
| Henry Cooper | Chair of the Board | 0.03% |
| Molly Joseph | Lead Independent Director | 0.01% |
| Glenn Eisenberg | Independent Director | -- |
| Bridget Karlin | Independent Director | -- |
| WCAS Management Corporation | -- | -- |
| Caitlin Zulla | Chief Executive Officer | -- |
| J. Martin | Chief Financial Officer | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-09 | Brett Brodnax | Independent Director | Other Acquisition | +19,358 | -- |
| 2026-06-09 | Glenn Eisenberg | Independent Director | Other Acquisition | +19,358 | -- |
| 2026-06-09 | Bridget Karlin | Independent Director | Other Acquisition | +19,358 | -- |
| 2026-06-09 | Henry Cooper | Chair of the Board | Other Acquisition | +19,358 | -- |
| 2026-06-09 | Molly Joseph | Lead Independent Director | Other Acquisition | +19,358 | -- |
| 2026-06-09 | Robert Mittl | Chief Quality Officer & Director | Other Acquisition | +19,358 | -- |
| 2026-06-09 | Matthew Lungren | Independent Director | Other Acquisition | +19,358 | -- |
| 2026-05-18 | Brett Brodnax | Independent Director | Open Market Acquisition | +35,000 | $7.25 |
| 2026-05-13 | Henry Cooper | Chair of the Board | Open Market Acquisition | +30,000 | $7.44 |
| 2026-02-24 | James Walker | Chief Accounting Officer | Other Acquisition | +12,414 | -- |
| 2025-12-11 | Brett Brodnax | Independent Director | Other Acquisition | +27,027 | -- |
| 2025-12-11 | Caitlin Zulla | Chief Executive Officer | Other Acquisition | +129,728 | -- |
| 2025-12-11 | J. Martin | Chief Financial Officer | Other Acquisition | +54,054 | -- |
| 2025-12-11 | Molly Joseph | Lead Independent Director | Other Acquisition | +13,513 | -- |
| 2025-12-11 | Molly Joseph | Lead Independent Director | Other Acquisition | +13,514 | -- |
| 2025-12-11 | Russell Stewart | Chief Medical Officer | Other Acquisition | +8,464 | -- |
| 2025-12-11 | Julie Szeker | Chief Legal Officer | Other Acquisition | +81,081 | -- |
| 2025-12-11 | Julie Szeker | Chief Legal Officer | Derivative Exercise and Retained | +66,182 | -- |
| 2025-12-11 | James Walker | Chief Accounting Officer | Other Acquisition | +4,932 | -- |
| 2025-12-10 | Welsh, Carson, Anderson & Stowe, L.P. | -- | Initial Statement of Beneficial | 0 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:55:13 · For reference only, not investment advice and not tailored to your situation.